[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

US3528417A - Wound release dressing - Google Patents

Wound release dressing Download PDF

Info

Publication number
US3528417A
US3528417A US666214A US3528417DA US3528417A US 3528417 A US3528417 A US 3528417A US 666214 A US666214 A US 666214A US 3528417D A US3528417D A US 3528417DA US 3528417 A US3528417 A US 3528417A
Authority
US
United States
Prior art keywords
fabric
wound
dressing
absorbent
dressings
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US666214A
Inventor
Jack H Gardner
Sam Rizzo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson
Original Assignee
Johnson and Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson and Johnson filed Critical Johnson and Johnson
Application granted granted Critical
Publication of US3528417A publication Critical patent/US3528417A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/02Adhesive bandages or dressings
    • A61F13/0203Adhesive bandages or dressings with fluid retention members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/01Non-adhesive bandages or dressings
    • A61F13/01021Non-adhesive bandages or dressings characterised by the structure of the dressing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/51Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the outer layers
    • A61F13/511Topsheet, i.e. the permeable cover or layer facing the skin
    • A61F13/51121Topsheet, i.e. the permeable cover or layer facing the skin characterised by the material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/51Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the outer layers
    • A61F13/511Topsheet, i.e. the permeable cover or layer facing the skin
    • A61F13/512Topsheet, i.e. the permeable cover or layer facing the skin characterised by its apertures, e.g. perforations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/24Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F2013/00089Wound bandages
    • A61F2013/00217Wound bandages not adhering to the wound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F2013/00089Wound bandages
    • A61F2013/00246Wound bandages in a special way pervious to air or vapours
    • A61F2013/00251Wound bandages in a special way pervious to air or vapours with macroscopic openings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F2013/00361Plasters
    • A61F2013/00727Plasters means for wound humidity control
    • A61F2013/00731Plasters means for wound humidity control with absorbing pads
    • A61F2013/00744Plasters means for wound humidity control with absorbing pads containing non-woven
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F2013/00361Plasters
    • A61F2013/00855Plasters pervious to air or vapours
    • A61F2013/00859Plasters pervious to air or vapours with macroscopic openings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/51Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the outer layers
    • A61F2013/51059Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the outer layers being sprayed with chemicals
    • A61F2013/51061Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the outer layers being sprayed with chemicals for rendering the surface hydrophobic

Definitions

  • Warner ABSTRACT A dressing adapted to be placed over open wounds in which the dressing or at least the wound-contacting surface of the dressing is formed of a fabric having a low degree of adhesion to healing wounds, the fabric comprising a perforate fiber base, the fibers of which are coated and bonded together with a plasticized polyvinyl chloride.
  • plasticizer is preferably of the polyester type, the polyester being a polyester of long chain poly basic acids esterified with polyhydric alcohols.
  • the plasticized polyvinyl chloride composition is present in an amount of 0.2 to 0.8 parts by weight based on the total weight of the plasticized polyvinyl chloridetreated fabric.
  • the fiber base may comprise an open-mesh gauze fabric but, preferably, is a bundled nonwoven fabric of the type disclosed, for example, in Griswold U.S. Pat. Nos. 3,081,514 and 3,081,515 where the fibers of the nonwoven fabric are bundled together'around openings formed through the fabric.
  • the present invention relates to surgical dressings and, more particularly, to dressings which possess a low degree of adhesion to the surface of healing wounds over which the same are placed and yet has many of the characteristics of gauze dressings in that the same is readily wetted and is sufficiently abrasive to permit the scrubbing of a wound area in cleaning the same by a physician.
  • the dressing serves primarily as a protection for the wound during the healing process.
  • the problem with generally used dressings is that during the healing process the eschar tends to form or grow around parts of the dressing, thus making it difficult later to remove the dressing without tearing the eschar or scab, and thus delaying the healing process.
  • the film which may be made of any smooth, flexible material, is perforated or cut to permit passage of fluids through the film to an absorbent backing.
  • Dressings have accordingly been proposed wherein the flexible, nonwater soluble, perforate film is bonded to or wrapped around an absorbent pad. Also, again utilizing the smooth surface concept for reducing wound adherence, dressings have been proposed made in the manner such as described in U.S. Pat. No. 3,006,338 wherein a fabric, preferably nonwoven, is impregnated with a polyethylene emulsion and then, after removal of the water, heated with one surface in intimate contact with another smooth surface to flatten out the deposits of polyethylene on the surface into smooth, film-like patches giving to the surface a smooth, fiber-free appearance.
  • a further disadvantage of filmed surface dressings is that in the formation of small dressing pads such, for example, as used in adhesive bandages or other dressing formation where the manufacture of the dressing involves an appreciable amount of folding, the film fiber laminates are difficult to handle and fold with most machinery. Also, many surgeons have been used to using the gauze dressings for wiping and cleaning the area of a wound where the wettable characteristics of the gauze and its slightly abrasive nature help substantially in this cleaning procedure. However, the film surface of the film-faced dressings is completely unsatisfactory for such cleaning because of its smooth and generally hydrophobic nature.
  • the preferred plasticizers are the polyesters of long chain poly basic acids esterifled with polyhydric alcohol. These tend to form an eutectic mixture with the polyvinyl chloride which mixture has a flow temperature appreciably above that generally used in the sterilization of dressings and the like by autoclave techniques.
  • a base fabrichaving an open mesh of about to 324 holes per square inch is preferably used.
  • a low count gauze may be employed, in the preferred practice of the present invention open-mesh nonwoven fabrics of the type described, for example, in Griswold U.S. Pat. Nos. 3,081,514 and 3,081,515 are used.
  • openings are formed through the nonwoven fabric by bundling or bunching of fibers together to form openings with peripheries of bunched or bundled fibers.
  • the perforate, nonwoven fabrics so formed are then generally treated with a binder such, for example, as a viscose binder, to improve the strength of the same.
  • a binder such, for example, as a viscose binder
  • These perforate, nonwoven fabrics may be overall bonded.
  • the preferred nonwoven perforate fabrics found most suitable for making the wound release dressings of the present invention are those which have a discontinuous bonding pattern.
  • One of the preferred discontinuing bonding patterns is that illustrated, for example, in the De Witt Ri Petterson et al. U.S. Pat. No. 2,705,687, in which the fibers of a nonwoven web are bonded together by an articulated multisegmented binder pattern, the individual segments of which are separated from, but hingedly connected to, each other by substantially unbonded length of fibers.
  • the base fabric has a staggered hole pattern such, for example, as illustrated in FIG. 1 of the present drawings and FIG. 9 of U.S. Pat. No. 3,081,515, rather than a square hole pattern such as is present in gauze or that illustrated, for example, in FIG. 1 of Griswold U.S. Pat. No. 3,081,515, as the staggered hole pattern also gives wound release fabrics that can be folded more readily.
  • the shape and staggering of the holes as well as the manner of bonding the nonwoven base fabric relate primarily to the ease in handling the final product with respect to folding in the making of composite dressings utilizing the same and apparently have no effect on the wound release characteristics of the material.
  • the plasticized polyvinyl chloride is applied by treating with an organic solution of the same.
  • Any of the dispersion grade polyvinyl chlorides such, for example, as QYNV (trade name for a percent polyvinyl chloride polymer of 1.40 specific gravity) may be used.
  • plasticizers examples include D.O.P. and the polymeric plasticizers sold under the trade name Paraplex.
  • the Paraplex plasticizers are polyester resins based on long chain polybasic acids esterfied with polyhydric alcohols such as glycerol or ethylene glycol. They come in different grades, Paraplex G-50 being one of the preferred.
  • D.O.P. is the name in the trade used for the monomeric plasticizer dioctyl phthalate. Any plasticizer may be used, but the nonmigrating polymeric types are preferred.
  • polyester where used as the plasticizer should be present in the polyvinyl chloride-polyester composition in amounts of .6 to 1.0 parts polyester per part of polyvinyl chloride.
  • Small amounts of stabilizer, such for example as dibutyltin maleate, may be added if desired, however, the presence of the same has no apparent effect on the release qualities of the wound release fabric.
  • a solution is first prepared containing approximately 50 to 80 parts of solvent, 10 to 25 parts of dispersion grade polyvinyl chloride, 10 to 15 parts of polyester, and .3 to 3 parts of stablizer.
  • the solution may be applied by any coating technique such as padding, gravure coating, knife coating, spraying, or the like.
  • the preferred practice is to use print coating as better control is obtained of the amount of pickup of coating solution by the base fabric.
  • the coating even though applied by printing in a pattern, is not restricted to the pattern in which it is applied but flows into the base fabric and surrounding fibers bonding together and encapsulating the fibers with which it comes in contact.
  • the base fabric After the base fabric has been coated with the organoslo, it is baked for approximately I minute at about 370 to 425F. to drive off the solvent and set the polyvinyl chloride-polyester composition in the fiber base.
  • the polyvinyl chloride and polyester appear to form an eutectic mixture which has a melting point well above 260F. This permits sterilization of the wound release fabrics by conventional steam sterilization without flow of the organosol to surrounding wrappings.
  • FIG. 1 is a perspective view of a wound release fabric made in accordance with the present invention
  • FIG. 2 is a photomicrograph of an enlarged portion of the fabric of FIG. 1;
  • FIG. 3 is an adhesive bandage utilizing the wound release fabric of FIG. 1;
  • FIG. 4 illustrates the pad of the bandage of FIG. 1 in manufacture
  • FIG. 5 illustrates a dressing that can be used either for cleaning or wound covering
  • FIG. 6 illustrates the folding of the dressing of FIG. 5.
  • FIG. 7 is a graph illustrating release as function of a composition pickup.
  • FIG. 1 a wound release fabric 10 which compresses a nonwoven fabric base 11 having openings 12 therethrough formed by the bundling of the fibers 13 around the periphery of the openings to form the same.
  • the openings 12 are elliptically shaped having a length of approximately 0.075" along the major axis of the ellipse and a width of approximately 0.025" along the minor axis. The same are also staggered with respect to each other which, as previously indicated, is the preferred construction although the invention is not limited thereto.
  • the fabric is prepared by print coating technique, it will be noted that the polyvinyl chloride-polyester composition 14 has impregnated into the fabric the composition not only coating a substantial amount of the fibers, but also penetrating into the fibers 13 of the fiber bundles.
  • wound release properties obtained through this construction is not understood as no smooth film surface is utilized as is done in the usual concept of dry wound release dressings.
  • substantially better wound release properties are obtained than, for example, can be obtained with a fabric in which the fibers are formed of polyethylene, although polyethylene as a film has excellent wound release properties.
  • the wound release is dependent on the degree of pickup by the fabric treated with the plasticized polyvinyl chloride.
  • a coating weight of at least 0.2 ounce per square yard with a rayon fabric of 0.7 ounce per square yard is required to give nonadherent properties.
  • the nonadhering properties that is the release from healing wound surfaces, substantially improves. This is illustrated in the graph of FIG. 7.
  • the best wound release properties are obtained with coating weights as high as 3 ounces per square yard of base fabric where the weight of the base fabric is approximately 0.7 ounces per square yard, it is generally desirable, particularly for small dressings such as used in the absorbent pads of adhesive bandages, that the coating weight not exceed about 1.2 ounces per square yard as higher coating weights appreciably effect the draping qualities of the fabric, the same becoming relatively stiff with coating weights as high as 3 ounces per square yard.
  • the wound contacting surface of the wound release fabric contains from about 0.2 to 0.8 parts by weight of plasticized polyvinyl chloride based on the total weight of the impregnated fibers.
  • the release characteristics of the wound release fabrics of the present invention as affected by the amount of polyvinyl chloride-polyester composition present is illustrated in the graph of FIG. 7 wherein the same are compared with the wound release property of conventional gauge and of an absorbent-backed perforate Mylar film.
  • These measurements are based on in vitro tests utilizing guinea pig skin freshly removed. Adherence to the raw side of such skin by the wound release fabric is measured by strain gauge after 7 hours contact.
  • This in vitro test method is particularly good for comparing several different wound release fabrics as a substantial portion of the skin can be removed and then cut into small squares of 2.5 cm. x 2.5 cm. permitting good comparative results for several samples, as the skin and conditions are identical.
  • the adherence results shown by the in vitro test correlate well with in vivo tests. The in vivo tests, however, are not as suitable for comparative test screening as only relatively small areas of wound are available for any single animal.
  • FIG. 3 of the drawings is illustrated an adhesive bandage 20 having the conventional pressure-sensitive adhesive coated tabs 21 and an absorbent pad 22.
  • absorbent pads are generally prepared with a facing fabric such as gauze, or the like which covers an underlying absorbent which may be further folds of gauze, or other absorbent material.
  • a facing fabric such as gauze, or the like which covers an underlying absorbent which may be further folds of gauze, or other absorbent material.
  • One of the preferred pad constructions is that disclosed, for example, in Ganz US. Pat. No. 2,893,388 wherein the covering gauze is folded so as to completely enclose the underlying absorbent, and the ends are folded inwardly to avoid any edges projecting beyond the pad.
  • FIG. 4 Such manner of folding is illustrated in FIG. 4, the absorbent 24 being completely enclosed within the overlying fabric 23.
  • the overlying fabric 23 is formed of wound release fabric such as that previously described, an embodiment of which is illustrated in FIGS. 1 and 2.
  • FIGS. 5 and 6 is illustrated a nonadherent dressing made in accordance with the present invention which is somewhat similar in construction to the presently available gauze dressings. These dressings generally have a size of anywhere from about 2 x 2 in the folded state to about 4 x 8 inches. The dressings are utilized not only for wound protection purposes but also frequently used for cleaning a wound area by the surgeon.
  • the dressing 25 comprises a nonwound adhering fabric 26 of the type, for example, illustrated in FIGS. 1 and 2 of the drawing. The fabric 26 is folded over an inner absorbent layer 27 of absorbent fibers such as cotton or the like.
  • the absorbent layer 27 may also consist of cellulosic wadding or a combination of cellulosic wadding and cotton fibers or other suitable absorbent material.
  • the dressing is first folded in the manner of FIG. 5 and then finally folded along line 28 into the form illustrated in the folded dressing of FIG. 6.
  • a plurality of dressings of this type may be used together, one placed on top of the other where it is desired to absorb substantial amounts of wound exudate or a single dressing may be placed over the immediate wound area and then the conventional gauze dressing placed over the same should further absorbent material be needed.
  • Dressings made in accordance with the present invention, placed in contact with a wound surface present to the wound surface a protective covering which has substantially less tendency to adhere to the underlying wound during the healing process than would the gauze of conventional gauze type dressing and are superior in wound release properties to some of the perforated film dressings.
  • the final dressing may take many forms in which the wound release fabric is utilized.
  • the wound release fabric may be used alone as the dressing material or may be placed over the wound and then backed by absorbent, the whole being taped to the patient.
  • One of the big advantages of the wound release fabric is the easy manner in which the same can be handled in preparing composite dressings in which the wound release fabric forms primarily the wound contacting surface.
  • the wound release fabrics are particularly useful in forming the absorbent pads of adhesive bandages such as illustrated in FIGS. 3 and 4 and larger dressings such as illustrated in FIGS. 5 and 6, where folding is required during the forming process.
  • a base material comprising a nonwoven fabric consisting of bundled rayon fibers held in place with a viscose binder printed in crosshatch pattern. It has a weight of 0.7 ounces per square yard and contains I65 holes per square inch.
  • An organosol is prepared by mixing until uniform, 400 parts by weight QYNV polyvinyl chloride resin, 303 parts Paraplex G -50 plasticizer and seven parts dibutyltin maleate stablilizer. This is reduced in viscosity by adding 2,800 parts of zylene.
  • the organosol is printed on the fabric by the direct gravure process using an engraved roll having 256 cells per square inch of 16 mils depth, the diameter of the roll being 9 inches. The roll gives uniform impregnation of the web.
  • the impregnated fabric is dried 1 minute at 350 F. and contains a coating weight of 0.5 ounce per square yard. This coated fabric is then slit into supply rolls of the desired width. The fabric is then folded on an adhesive bandage making machine to form an absorbent pad with backing absorbent as illustrated in FIGS. 3 and 4, which is secured to a flexible backing coated with pressure-sensitive adhesive for formation of an adhesive bandage.
  • a perforate fiber fabric having at least one side thereof adapted to contact a wound surface and at least said wound contacting side being impregnated with plasticized polyvinyl chloride in an amount of not less than about 0.2 parts by weight plasticized polyvinyl chloride based on the total weight of impregnated fibers.
  • a dressing of claim 2 wherein said nonwoven fabric has the openings therethrough edged by fiber bundles, the fiber bundles being impregnated by plasticized polyvinyl chloride.
  • a dressing of claim 1 wherein said perforate fiber fabric is gauze.
  • a dressing of claim 8 wherein said fabric is a perforate nonwoven fabric having fibers thereof bonded together by an articulated multisegmented binder pattern the individual segments of which are separated from, but connected to, each other by length of fiber substantially unbonded by the binder of said pattern.
  • a dressing of claim 7 wherein said fabric and absorbent are secured to a flexible sheet having at leat a portion thereof extending beyond opposing edges of said fabric and said absorbent to form flexible tabs, said flexible tabs containing a pressure-sensitive adhesive thereon for securing said dressing to a patient.
  • a dressing of claim 1 1 wherein said fabric is a nonwoven fabric having openings, said openings being edged by fiber bundles the fiber bundles being impregnated by plasticized polyvinyl chloride.
  • a dressing of claim 12 wherein said plasticizer is a resin polymer comprising a polyester of long chain polybasic acid esterified with polyhydric alcohol.

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Materials For Medical Uses (AREA)

Description

United States Patent [72] Inventors Jack H. Gardner;
Sam Rizzo, Highland Park, NJ. [211 App]. No. 666,214
[22] Filed Sept. 7, 1967 [45] Patented Sept. 15, 1970 [73] Assignee Johnson & Johnson,
a corporation of New Jersey [54] WOUND RELEASE DRESSING 13 Claims, 7 Drawing Figs.
[52] U.S. Cl 128/156 [51] lnt.Cl A61] 15/00 [50] Field ofSearch ..128/155-157 [56] References Cited UNITED STATES PATENTS 2,371,001 3/1945 Stone 128/156X 2,893,388 7/1959 Ganz 128/156 2,923,298 2/ 1960 Dockstader et al. 128/156X 2,992,644 7/1961 Platinga et al. 128/156 3,416,525 12/1968 Yeremian 128/156 Primary Examiner--L.W. Trapp Attorneys-Alexander T. Kardos, Arnold S. Worfolk and Harold L. Warner ABSTRACT: A dressing adapted to be placed over open wounds in which the dressing or at least the wound-contacting surface of the dressing is formed of a fabric having a low degree of adhesion to healing wounds, the fabric comprising a perforate fiber base, the fibers of which are coated and bonded together with a plasticized polyvinyl chloride. The
plasticizer is preferably of the polyester type, the polyester being a polyester of long chain poly basic acids esterified with polyhydric alcohols. The plasticized polyvinyl chloride composition is present in an amount of 0.2 to 0.8 parts by weight based on the total weight of the plasticized polyvinyl chloridetreated fabric. The fiber base may comprise an open-mesh gauze fabric but, preferably, is a bundled nonwoven fabric of the type disclosed, for example, in Griswold U.S. Pat. Nos. 3,081,514 and 3,081,515 where the fibers of the nonwoven fabric are bundled together'around openings formed through the fabric.
Patented Sept. 15, 19 70 28, 7 Sheet 2 Gauze ATTORNEY WOUND RELEASE DRESSING BRIEF SUMMARY OF THE INVENTION The present invention relates to surgical dressings and, more particularly, to dressings which possess a low degree of adhesion to the surface of healing wounds over which the same are placed and yet has many of the characteristics of gauze dressings in that the same is readily wetted and is sufficiently abrasive to permit the scrubbing of a wound area in cleaning the same by a physician.
It has generally been recognized that in the natural healing of animal wounds, the dressing serves primarily as a protection for the wound during the healing process. The problem with generally used dressings is that during the healing process the eschar tends to form or grow around parts of the dressing, thus making it difficult later to remove the dressing without tearing the eschar or scab, and thus delaying the healing process. In order to overcome this, it has heretofore been proposed to use a smooth, thin, flexible, nonwater soluble film in direct contact with the wound. The film, which may be made of any smooth, flexible material, is perforated or cut to permit passage of fluids through the film to an absorbent backing. Dressings have accordingly been proposed wherein the flexible, nonwater soluble, perforate film is bonded to or wrapped around an absorbent pad. Also, again utilizing the smooth surface concept for reducing wound adherence, dressings have been proposed made in the manner such as described in U.S. Pat. No. 3,006,338 wherein a fabric, preferably nonwoven, is impregnated with a polyethylene emulsion and then, after removal of the water, heated with one surface in intimate contact with another smooth surface to flatten out the deposits of polyethylene on the surface into smooth, film-like patches giving to the surface a smooth, fiber-free appearance. One of the difficulties with film surfaced dressings is that their rate of absorption is dependent to a substantial degree on the size and number of holes in the film which forms the wound-contacting surface of the dressing. If the holes are too small, there is a tendency for the same to plug, blocking the flow of wound exudate. If the holes are too large, then there is a tendency for the surface of the wound to come in contact with the fibers of the underlying absorbent and bond to the same, thus defeating to a substantial degree the use of the smooth film covering for obtaining nonadherency. A further disadvantage of filmed surface dressings is that in the formation of small dressing pads such, for example, as used in adhesive bandages or other dressing formation where the manufacture of the dressing involves an appreciable amount of folding, the film fiber laminates are difficult to handle and fold with most machinery. Also, many surgeons have been used to using the gauze dressings for wiping and cleaning the area of a wound where the wettable characteristics of the gauze and its slightly abrasive nature help substantially in this cleaning procedure. However, the film surface of the film-faced dressings is completely unsatisfactory for such cleaning because of its smooth and generally hydrophobic nature.
These problems have now been obviated by the discovery that open-mesh fiber base fabrics, when impregnated with a plasticized polyvinyl chloride have excellent wound release characteristics as long as the plasticized polyvinyl chloride is present in amounts of at least 20 percent by weight of the impregnated fabric. Also, such a dressing material wets readily and has sufficient abrasive characteristics to permit its use in cleaning of wound areas. Not only do fabrics so treated have excellent wound release properties as well as wetting and mildly abrasive characteristics, but the same have much the appearance of the treated fabric. Also, the handling qualities of fabric so treated is substantially improved the same being readily handled and folded in the manufacture of dressings of different types. Furthermore, wound exudate readily passes through such dressing materials into backing absorbent where a backing absorbent is used as a part of the dressing.
The preferred plasticizers are the polyesters of long chain poly basic acids esterifled with polyhydric alcohol. These tend to form an eutectic mixture with the polyvinyl chloride which mixture has a flow temperature appreciably above that generally used in the sterilization of dressings and the like by autoclave techniques.
DETAILED DESCRIPTION OF INVENTION In preparing the wound release dressings of the present invention, a base fabrichaving an open mesh of about to 324 holes per square inch is preferably used. Although a low count gauze may be employed, in the preferred practice of the present invention open-mesh nonwoven fabrics of the type described, for example, in Griswold U.S. Pat. Nos. 3,081,514 and 3,081,515 are used. In fabrics of this type, openings are formed through the nonwoven fabric by bundling or bunching of fibers together to form openings with peripheries of bunched or bundled fibers. The perforate, nonwoven fabrics so formed are then generally treated with a binder such, for example, as a viscose binder, to improve the strength of the same. These perforate, nonwoven fabrics may be overall bonded. However, the preferred nonwoven perforate fabrics found most suitable for making the wound release dressings of the present invention are those which have a discontinuous bonding pattern. One of the preferred discontinuing bonding patterns is that illustrated, for example, in the De Witt Ri Petterson et al. U.S. Pat. No. 2,705,687, in which the fibers of a nonwoven web are bonded together by an articulated multisegmented binder pattern, the individual segments of which are separated from, but hingedly connected to, each other by substantially unbonded length of fibers. It is found that with the intermittent or discontinuous bonding of the base nonwoven fabric the same can be more readily folded, with less tendency to spring back, than with overall bonded materials. Also, in the preferred practice, the base fabric has a staggered hole pattern such, for example, as illustrated in FIG. 1 of the present drawings and FIG. 9 of U.S. Pat. No. 3,081,515, rather than a square hole pattern such as is present in gauze or that illustrated, for example, in FIG. 1 of Griswold U.S. Pat. No. 3,081,515, as the staggered hole pattern also gives wound release fabrics that can be folded more readily. However, the shape and staggering of the holes as well as the manner of bonding the nonwoven base fabric relate primarily to the ease in handling the final product with respect to folding in the making of composite dressings utilizing the same and apparently have no effect on the wound release characteristics of the material.
The plasticized polyvinyl chloride is applied by treating with an organic solution of the same. Any of the dispersion grade polyvinyl chlorides such, for example, as QYNV (trade name for a percent polyvinyl chloride polymer of 1.40 specific gravity) may be used.
Examples of commercially available plasticizers are D.O.P. and the polymeric plasticizers sold under the trade name Paraplex. The Paraplex plasticizers are polyester resins based on long chain polybasic acids esterfied with polyhydric alcohols such as glycerol or ethylene glycol. They come in different grades, Paraplex G-50 being one of the preferred. D.O.P. is the name in the trade used for the monomeric plasticizer dioctyl phthalate. Any plasticizer may be used, but the nonmigrating polymeric types are preferred.
The polyester where used as the plasticizer should be present in the polyvinyl chloride-polyester composition in amounts of .6 to 1.0 parts polyester per part of polyvinyl chloride. Small amounts of stabilizer, such for example as dibutyltin maleate, may be added if desired, however, the presence of the same has no apparent effect on the release qualities of the wound release fabric.
in treating the fiber base, a solution is first prepared containing approximately 50 to 80 parts of solvent, 10 to 25 parts of dispersion grade polyvinyl chloride, 10 to 15 parts of polyester, and .3 to 3 parts of stablizer. The solution may be applied by any coating technique such as padding, gravure coating, knife coating, spraying, or the like. However, the preferred practice is to use print coating as better control is obtained of the amount of pickup of coating solution by the base fabric. As the organisol solution is sufficiently fluid to wick into the base fabric, the coating, even though applied by printing in a pattern, is not restricted to the pattern in which it is applied but flows into the base fabric and surrounding fibers bonding together and encapsulating the fibers with which it comes in contact.
After the base fabric has been coated with the organoslo, it is baked for approximately I minute at about 370 to 425F. to drive off the solvent and set the polyvinyl chloride-polyester composition in the fiber base. As previously indicated, the polyvinyl chloride and polyester appear to form an eutectic mixture which has a melting point well above 260F. This permits sterilization of the wound release fabrics by conventional steam sterilization without flow of the organosol to surrounding wrappings.
The practice of the present invention is further described with reference to the drawings in which:
FIG. 1 is a perspective view of a wound release fabric made in accordance with the present invention;
FIG. 2 is a photomicrograph of an enlarged portion of the fabric of FIG. 1;
FIG. 3 is an adhesive bandage utilizing the wound release fabric of FIG. 1;
FIG. 4 illustrates the pad of the bandage of FIG. 1 in manufacture;
FIG. 5 illustrates a dressing that can be used either for cleaning or wound covering;
FIG. 6 illustrates the folding of the dressing of FIG. 5; and
FIG. 7 is a graph illustrating release as function of a composition pickup.
Referring to the drawings, in FIG. 1 is illustrated a wound release fabric 10 which compresses a nonwoven fabric base 11 having openings 12 therethrough formed by the bundling of the fibers 13 around the periphery of the openings to form the same. This is best illustrated in the microphotograph in FIG. 2. The openings 12 are elliptically shaped having a length of approximately 0.075" along the major axis of the ellipse and a width of approximately 0.025" along the minor axis. The same are also staggered with respect to each other which, as previously indicated, is the preferred construction although the invention is not limited thereto. Although the fabric is prepared by print coating technique, it will be noted that the polyvinyl chloride-polyester composition 14 has impregnated into the fabric the composition not only coating a substantial amount of the fibers, but also penetrating into the fibers 13 of the fiber bundles.
The reason for the excellent wound release properties obtained through this construction is not understood as no smooth film surface is utilized as is done in the usual concept of dry wound release dressings. However, substantially better wound release properties are obtained than, for example, can be obtained with a fabric in which the fibers are formed of polyethylene, although polyethylene as a film has excellent wound release properties. The wound release is dependent on the degree of pickup by the fabric treated with the plasticized polyvinyl chloride. Thus, for example, a coating weight of at least 0.2 ounce per square yard with a rayon fabric of 0.7 ounce per square yard is required to give nonadherent properties. As the coating weight is increased, the nonadhering properties, that is the release from healing wound surfaces, substantially improves. This is illustrated in the graph of FIG. 7. Although the best wound release properties are obtained with coating weights as high as 3 ounces per square yard of base fabric where the weight of the base fabric is approximately 0.7 ounces per square yard, it is generally desirable, particularly for small dressings such as used in the absorbent pads of adhesive bandages, that the coating weight not exceed about 1.2 ounces per square yard as higher coating weights appreciably effect the draping qualities of the fabric, the same becoming relatively stiff with coating weights as high as 3 ounces per square yard. Thus on a fiber-plasticized polyvinyl chloride weight basis, the wound contacting surface of the wound release fabric contains from about 0.2 to 0.8 parts by weight of plasticized polyvinyl chloride based on the total weight of the impregnated fibers.
The release characteristics of the wound release fabrics of the present invention as affected by the amount of polyvinyl chloride-polyester composition present is illustrated in the graph of FIG. 7 wherein the same are compared with the wound release property of conventional gauge and of an absorbent-backed perforate Mylar film. These measurements are based on in vitro tests utilizing guinea pig skin freshly removed. Adherence to the raw side of such skin by the wound release fabric is measured by strain gauge after 7 hours contact. This in vitro test method is particularly good for comparing several different wound release fabrics as a substantial portion of the skin can be removed and then cut into small squares of 2.5 cm. x 2.5 cm. permitting good comparative results for several samples, as the skin and conditions are identical. The adherence results shown by the in vitro test correlate well with in vivo tests. The in vivo tests, however, are not as suitable for comparative test screening as only relatively small areas of wound are available for any single animal.
In FIG. 3 of the drawings is illustrated an adhesive bandage 20 having the conventional pressure-sensitive adhesive coated tabs 21 and an absorbent pad 22. Such absorbent pads are generally prepared with a facing fabric such as gauze, or the like which covers an underlying absorbent which may be further folds of gauze, or other absorbent material. One of the preferred pad constructions is that disclosed, for example, in Ganz US. Pat. No. 2,893,388 wherein the covering gauze is folded so as to completely enclose the underlying absorbent, and the ends are folded inwardly to avoid any edges projecting beyond the pad. Such manner of folding is illustrated in FIG. 4, the absorbent 24 being completely enclosed within the overlying fabric 23. In the practice of the present invention the overlying fabric 23 is formed of wound release fabric such as that previously described, an embodiment of which is illustrated in FIGS. 1 and 2.
In FIGS. 5 and 6 is illustrated a nonadherent dressing made in accordance with the present invention which is somewhat similar in construction to the presently available gauze dressings. These dressings generally have a size of anywhere from about 2 x 2 in the folded state to about 4 x 8 inches. The dressings are utilized not only for wound protection purposes but also frequently used for cleaning a wound area by the surgeon. Referring to FIGS. 5 and 6, the dressing 25 comprises a nonwound adhering fabric 26 of the type, for example, illustrated in FIGS. 1 and 2 of the drawing. The fabric 26 is folded over an inner absorbent layer 27 of absorbent fibers such as cotton or the like. The absorbent layer 27 may also consist of cellulosic wadding or a combination of cellulosic wadding and cotton fibers or other suitable absorbent material. The dressing is first folded in the manner of FIG. 5 and then finally folded along line 28 into the form illustrated in the folded dressing of FIG. 6. A plurality of dressings of this type may be used together, one placed on top of the other where it is desired to absorb substantial amounts of wound exudate or a single dressing may be placed over the immediate wound area and then the conventional gauze dressing placed over the same should further absorbent material be needed. Dressings, made in accordance with the present invention, placed in contact with a wound surface present to the wound surface a protective covering which has substantially less tendency to adhere to the underlying wound during the healing process than would the gauze of conventional gauze type dressing and are superior in wound release properties to some of the perforated film dressings.
The final dressing may take many forms in which the wound release fabric is utilized. Thus, the wound release fabric may be used alone as the dressing material or may be placed over the wound and then backed by absorbent, the whole being taped to the patient. One of the big advantages of the wound release fabric, however, is the easy manner in which the same can be handled in preparing composite dressings in which the wound release fabric forms primarily the wound contacting surface. Thus, the wound release fabrics are particularly useful in forming the absorbent pads of adhesive bandages such as illustrated in FIGS. 3 and 4 and larger dressings such as illustrated in FIGS. 5 and 6, where folding is required during the forming process.
The practice of the present invention is further illustrated by the following example which is given for purpose of illustration only, the invention not being limited thereto.
A base material is used comprising a nonwoven fabric consisting of bundled rayon fibers held in place with a viscose binder printed in crosshatch pattern. It has a weight of 0.7 ounces per square yard and contains I65 holes per square inch. An organosol is prepared by mixing until uniform, 400 parts by weight QYNV polyvinyl chloride resin, 303 parts Paraplex G -50 plasticizer and seven parts dibutyltin maleate stablilizer. This is reduced in viscosity by adding 2,800 parts of zylene. The organosol is printed on the fabric by the direct gravure process using an engraved roll having 256 cells per square inch of 16 mils depth, the diameter of the roll being 9 inches. The roll gives uniform impregnation of the web. The impregnated fabric is dried 1 minute at 350 F. and contains a coating weight of 0.5 ounce per square yard. This coated fabric is then slit into supply rolls of the desired width. The fabric is then folded on an adhesive bandage making machine to form an absorbent pad with backing absorbent as illustrated in FIGS. 3 and 4, which is secured to a flexible backing coated with pressure-sensitive adhesive for formation of an adhesive bandage.
Particular embodiments of the invention have been used to illustrate the same. The invention, however, is not limited to these specific embodiments. In view of the foregoing disclosure, variation or modifications thereof will be apparent, it is intended to include within the invention all such variations and modifications except as do not come within the scope of the appended claims.
We claim:
1. In a dressing a perforate fiber fabric having at least one side thereof adapted to contact a wound surface and at least said wound contacting side being impregnated with plasticized polyvinyl chloride in an amount of not less than about 0.2 parts by weight plasticized polyvinyl chloride based on the total weight of impregnated fibers.
Z. A dressing of claim 1 wherein said perforate fiber fabric is a nonwoven fabric.
3. A dressing of claim 2 wherein said nonwoven fabric has the openings therethrough edged by fiber bundles, the fiber bundles being impregnated by plasticized polyvinyl chloride.
4. A dressing of claim 1 wherein said fabric contains dispersed therethrough and as a fiber coating, plasticized polyvinyl chloride said plasticized polyvinyl chloride being present in an amount of 0.2 to 0.8 part by weight based on the total weight of the plasticized polyvinyl chloride impregnated fabric.
5. A dressing of claim 4 in which the fibers of said fabric are rayon fibers.
6. A dressing of claim 1 wherein said perforate fiber fabric is gauze.
7. A dressing of claim 4 wherein said fabric is backed by an I absorbent.
8. A dressing of claim 7 wherein said fabric is folded around said absorbent.
9. A dressing of claim 8 wherein said fabric is a perforate nonwoven fabric having fibers thereof bonded together by an articulated multisegmented binder pattern the individual segments of which are separated from, but connected to, each other by length of fiber substantially unbonded by the binder of said pattern.
10. A dressing of claim 7 wherein said fabric and absorbent are secured to a flexible sheet having at leat a portion thereof extending beyond opposing edges of said fabric and said absorbent to form flexible tabs, said flexible tabs containing a pressure-sensitive adhesive thereon for securing said dressing to a patient.
11. A dressing of claim 10 wherein said fabric is folded around said absorbent.
12. A dressing of claim 1 1 wherein said fabric is a nonwoven fabric having openings, said openings being edged by fiber bundles the fiber bundles being impregnated by plasticized polyvinyl chloride.
13. A dressing of claim 12 wherein said plasticizer is a resin polymer comprising a polyester of long chain polybasic acid esterified with polyhydric alcohol.
US666214A 1967-09-07 1967-09-07 Wound release dressing Expired - Lifetime US3528417A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66621467A 1967-09-07 1967-09-07

Publications (1)

Publication Number Publication Date
US3528417A true US3528417A (en) 1970-09-15

Family

ID=24673286

Family Applications (1)

Application Number Title Priority Date Filing Date
US666214A Expired - Lifetime US3528417A (en) 1967-09-07 1967-09-07 Wound release dressing

Country Status (2)

Country Link
US (1) US3528417A (en)
GB (1) GB1232408A (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3678933A (en) * 1970-07-17 1972-07-25 Moore Perk Corp Surgical sponge or bandage
US3703897A (en) * 1969-10-09 1972-11-28 Kendall & Co Hydrophobic non-adherent wound dressing
US3780731A (en) * 1969-03-27 1973-12-25 Zimmer Manuf Co Traction strip
US3811438A (en) * 1972-03-30 1974-05-21 G Economou Adhesive tapes and bandages
US3885559A (en) * 1972-07-24 1975-05-27 George J Economou Process for the reduction of pain in the removal of adhesive tapes and bandages
US3888248A (en) * 1973-07-23 1975-06-10 Moore Perk Corp Abdominal pad or surgical dressing
US3900027A (en) * 1974-01-02 1975-08-19 Pall Corp Process for preparing integral absorbent pad bandages and product
US3920010A (en) * 1974-08-08 1975-11-18 Kendall & Co Controlled pressure surgical dressing and method of making same
US4233976A (en) * 1978-07-06 1980-11-18 Minnesota Mining And Manufacturing Company Styptic device
EP0342950A2 (en) * 1988-05-18 1989-11-23 SMITH & NEPHEW plc Dressings
US5613942A (en) * 1994-10-04 1997-03-25 Minnesota Mining And Manufacturing Company Adhesive sheet material suitable for use on wet surfaces
US20090165817A1 (en) * 2003-06-03 2009-07-02 Policrom Screens S.P.A. System for roll impregnation
US20110218509A1 (en) * 2010-03-04 2011-09-08 Kalliope Dontas Enclosing bandage for providing comfortable wound care and limiting fluid leakage

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2153229B (en) * 1984-01-25 1987-06-10 Vernon Carus Ltd Wound dressing

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3780731A (en) * 1969-03-27 1973-12-25 Zimmer Manuf Co Traction strip
US3703897A (en) * 1969-10-09 1972-11-28 Kendall & Co Hydrophobic non-adherent wound dressing
US3678933A (en) * 1970-07-17 1972-07-25 Moore Perk Corp Surgical sponge or bandage
US3811438A (en) * 1972-03-30 1974-05-21 G Economou Adhesive tapes and bandages
US3885559A (en) * 1972-07-24 1975-05-27 George J Economou Process for the reduction of pain in the removal of adhesive tapes and bandages
US3888248A (en) * 1973-07-23 1975-06-10 Moore Perk Corp Abdominal pad or surgical dressing
US3900027A (en) * 1974-01-02 1975-08-19 Pall Corp Process for preparing integral absorbent pad bandages and product
US3920010A (en) * 1974-08-08 1975-11-18 Kendall & Co Controlled pressure surgical dressing and method of making same
US4233976A (en) * 1978-07-06 1980-11-18 Minnesota Mining And Manufacturing Company Styptic device
EP0342950A2 (en) * 1988-05-18 1989-11-23 SMITH & NEPHEW plc Dressings
EP0342950A3 (en) * 1988-05-18 1990-08-01 Smith & Nephew Plc Dressings
AU621886B2 (en) * 1988-05-18 1992-03-26 Smith & Nephew Plc Dressings
US5613942A (en) * 1994-10-04 1997-03-25 Minnesota Mining And Manufacturing Company Adhesive sheet material suitable for use on wet surfaces
US20090165817A1 (en) * 2003-06-03 2009-07-02 Policrom Screens S.P.A. System for roll impregnation
US7712414B2 (en) * 2003-06-03 2010-05-11 Policross Screens S.P.A. System for roll impregnation
US20110218509A1 (en) * 2010-03-04 2011-09-08 Kalliope Dontas Enclosing bandage for providing comfortable wound care and limiting fluid leakage
US8563798B2 (en) 2010-03-04 2013-10-22 Kalliope Dontas Enclosing bandage for providing comfortable wound care and limiting fluid leakage

Also Published As

Publication number Publication date
GB1232408A (en) 1971-05-19

Similar Documents

Publication Publication Date Title
US3838692A (en) Hydrophobic sheet with hydrophilic passages
US3528417A (en) Wound release dressing
US3523536A (en) Absorbent fibrous products
US2896626A (en) Disposable absorbent pad
US4713069A (en) Baffle having zoned water vapor permeability
DE602004004337T2 (en) Absorbent article
US4360015A (en) Multilayer absorbent structure
RU2246320C2 (en) Microporous films having flocked fibers
US4758239A (en) Breathable barrier
DE69636984T2 (en) THIN FILM PATTERN WITH ABSORBER EDGE
US4551377A (en) Absorbent pads
US3521624A (en) Microorganism growth inhibiting fiber products
US20070299383A1 (en) Foam layer cohesive articles and wound care bandages and methods of making and using same
JP2001509056A (en) Coating material
CN107548300A (en) Wound applies pad and the self-adhering type component of pad is applied including wound
RU2245698C2 (en) Absorbing article comprising flocculated fibers
JPS605703B2 (en) Nonwoven fabric and its manufacturing method
BR102012023829A2 (en) resilient absorbent composite material
US3955577A (en) Resin treated absorbent pad or web for body fluids
CA2044260C (en) Orthopaedic cast system and components therefor
DE69313860T2 (en) ABSORBENT SELF-ADHESIVE ELASTIC BANDAGE
US5380260A (en) Medical paddings
JPS58188450A (en) Medical fabric
US5531667A (en) Orthopaedic casting bandages
US2229061A (en) Fibrous absorbent body and method of making same